Supplemental material
OncoImmunology
Volume 13, 2024 - Issue 1
Open access
811
Views
0
CrossRef citations to date
0
Altmetric
Original Research
An oncogene regulating chromatin favors response to immunotherapy
Oncogene CHAF1A and immunotherapy outcomes
Leqian Yinga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, China;b Department of Oncology, Zhong-Da Hospital, Medicine School, Southeast University, Nanjing, ChinaView further author information
, Zhangmin Hua Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Yi Luc Department of Oncology, Wujin Hospital Affiliated with Jiangsu University, Changzhou, ChinaView further author information
, Qing Taoa Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Fen Xionga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Yongqian Shud Department of Oncology, Jiangsu Province Hospital & The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaView further author information
, Yufei Yanga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Xuehan Qiaoa Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Chen Penga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Yuchun Jianga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Miao Hana Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Min Xue Department of Gastroenterology, Digestive Disease Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
, Xiaoqin Lia Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaView further author information
& Deqiang Wanga Department of Oncology, Digestive Disease Institute&Cancer Institute of Jiangsu University, Affiliated Hospital of Jiangsu University, Zhenjiang, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-8411-312XView further author information
show allhttps://orcid.org/0000-0002-8411-312XView further author information
Article: 2303195
|
Received 10 Sep 2023, Accepted 02 Jan 2024, Published online: 09 Jan 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.